Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 2000, p. 134-138, Vol. 44, No. 1
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Chemical Specificity of the PDR5
Multidrug Resistance Gene Product of Saccharomyces
cerevisiae Based on Studies with
Tri-n-Alkyltin Chlorides
John
Golin,1,*
Alisa
Barkatt,1
Susan
Cronin,1,3
George
Eng,4 and
Leopold
May2
Departments of
Biology1 and
Chemistry,2 The Catholic University of
America, Washington, D.C. 20064; Department of Biology,
Immaculata College, Immaculata, Pennsylvania
193453; and Department of Chemistry and
Physics, University of the District of Columbia, Washington, D.C.
200084
Received 15 July 1999/Returned for modification 16 September
1999/Accepted 12 October 1999
 |
ABSTRACT |
To understand the chemical basis of action for the
PDR5-encoded multidrug resistance transporter of
Saccharomyces cerevisiae, we compared the relative
hypersensitivities of the wild-type (RW2802) and null mutant strains
toward a series of tri-n-alkyltin compounds. These
compounds differ from each other in a systematic fashion
either by
hydrocarbon chain length or by anion composition. Using
zone-of-inhibition and fixed-concentration assays, we found that the
ethyl, propyl, and butyl compounds are strong PDR5
substrates, whereas the methyl and pentyl compounds are weak. We
conclude that hydrophobicity and anion makeup are relatively
unimportant factors in determining whether a tri-n-alkyltin
compound is a good PDR5 substrate but that the dissociation
of the compound and the molecular size are significant.
 |
INTRODUCTION |
The yeast PDR5 gene
encodes a 160-kDa protein that is a member of the ATP-binding cassette
transport superfamily (1). Loss-of-function mutations in
this gene create broad-spectrum hypersensitivity to a large array of
chemically diverse inhibitors because of an inability to cause efflux
of such compounds (11). Overexpression of the
PDR5 gene product, in contrast, results in multidrug
resistance (MDR) (1, 14). As is the case for most of the
other MDR proteins encountered in eucaryotes, the chemical basis for
the broad specificities of the PDR5 transporter remains
unknown. Precise knowledge of the mechanism by which transporters
recognize their substrates might have important clinical ramifications.
Furthermore, it could help explain the basis for the interesting
classes of MDR mutants with altered specificities that have been
identified for yeast (3) and mammalian (6, 12) cells.
Most models of MDR action invoke the requirement of hydrophobicity
(5). This idea is based upon the fact that several
structurally related drugs that differ in their ability to be
transported by the mammalian MDR transporter differ in their relative
hydrophobicities, as measured by their water/octanol partitioning ratio
(logP) (15, 18). This observation was used as evidence for
proposing that the mammalian MDR protein is a flippase. Thus, a drug
must be intercalated into the lipid bilayer before it interacts with a binding site on the efflux protein (5). To address various models of PDR5 substrate recognition, we analyzed the
abilities of the wild-type and isogenic null mutant proteins to mediate resistance toward a family of structurally related
tri-n-alkyltin compounds that interfere with mitochondrial
ATPase activity (2) and differ systematically either by the
length of the hydrocarbon chain or by the counterion.
Zone-of-inhibition and fixed-concentration assays were used so that
quantitative comparisons could be made with a high degree of accuracy.
The results obtained were compared to measures of hydrophobicity, ion
dissociation, and molecular size.
 |
MATERIALS AND METHODS |
Yeast strains.
The two isogenic strains of
Saccharomyces cerevisiae used in this study were previously
described (11). RW2802 contains a functional PDR5
gene, while JG436 has a large Tn5 insertion mutation in the
promoter region and makes no detectable transcript (14). The
SIN4 (DY150) and sin4::URA3
(DY1704) strains were generously provided by David Stillwell and are
described elsewhere (7). Isogenic strains bearing
snq2::URA3 disruptions were constructed by transforming RW2802 and JG436 to create PDR5
snq2::URA3 (JG545) and
pdr5::Tn5
snq2::URA3 (JG546) mutants,
respectively. To do this, 1 µg of pAE9 DNA, kindly provided by Scott
Moye-Rowley, was linearized with SacI and SalI
prior to transformation of yeast cells with a Gietz Lab Transformation
Kit (Tetra Link, Amherst, N.Y.). The resulting chromosomal disruptions
were verified by Southern hybridization. In addition, transformants
were tested for hypersensitivity toward
4-nitroquinoline-n-oxide, which is characteristic of
snq2 but not pdr5 mutants. The transformant strains selected exhibited this phenotype. Thus, both strains bearing
snq2::URA3 disruptions were
hypersensitive to 4-nitroquinoline-n-oxide when compared to
the isogenic, wild-type strain (RW2802) and the pdr5 mutant
strain (JG436). Once the constructions were verified, a single
transformant of each strain (JG436, JG545, and JG546) was used in all
of the experiments described below. For all of the assays, saturated
cultures of yeasts grown in liquid medium were used.
Tri-n-alkyltin compounds and other inhibitors.
Triphenyltin chloride, tri-n-pentyltin chloride, and
tri-n-butyltin chloride, acetate, and bromide were purchased
from Aldrich (Milwaukee, Wis.). Tri-n-ethyltin chloride was
obtained from Stem Chemicals (Newburyport, Mass.).
Tri-n-methyltin chloride was purchased from Organometallics,
Inc. (Hampstead, N.H.). Tri-n-propyltin chloride was
obtained from Alfa (Ward Hill, Mass.). Chloramphenicol, clotrimazole,
and cycloheximide were all purchased from Sigma Chemical Company (St.
Louis, Mo.). No further purification of these compounds was done. The
compounds were dissolved in dimethyl sulfoxide (DMSO) (Sigma). When
DMSO was applied by itself in the concentrated form, no zone of
inhibition was observed with any strain.
Zone-of-inhibition assays.
The degree of resistance toward
the tri-n-alkyltin compounds was determined quantitatively
by use of a previously described zone-of-inhibition assay
(14). Each determination (see Table 1) is the average for at
least three samples. For each sample, 0.2 ml of culture grown in
yeast-peptone-dextrose medium (about 107 cells) was mixed
with 4 ml of 1% agar (melted in doubly deionized water and autoclaved
prior to use), and the mixture was plated on yeast-peptone-glycerol
(YPG) medium (containing, per liter, 20 g of peptone, 10 g of
yeast extract, 20 ml of glycerol, and 10 g of agar, except for
testing resistance to clotrimazole and cycloheximide, for which 20 g of dextrose was used instead of glycerol). YPG plates were incubated
for 72 h at 30°C before measurement. Dextrose plates were scored
at 48 h following incubation at 30°C. YPG plates were used for
the tri-n-alkyltin compounds because these inhibitors act on
the mitochondrial ATPase and glycerol is nonfermentable. Dextrose
plates were used for nonmitochondrial inhibitors because they permit
faster scoring. Very similar results are obtained, however, when
glycerol plates are used (J. Golin, unpublished observations).
Fixed-concentration assays.
To make medium with a known
concentration of inhibitor, YPG medium was prepared as described above
and autoclaved. Following sterilization, a particular
tri-n-alkyltin inhibitor was dissolved in DMSO to a desired
concentration, and the mixture was added to medium that had been cooled
to 60°C in a water bath. The medium was then poured into petri
dishes. To test cells for the ability to grow on medium with a
particular concentration of inhibitor, overnight cultures of cells were
diluted to 5 × 106 cells. Two samples (10 µl) of
the dilution were applied to the petri dishes. The dishes were
incubated for 48 h at 30°C and scored for the presence or
absence of growth.
Calculation of logP.
The logP was calculated by use of the
ClogP program obtained from BioByte Corporation (Claremont, Calif.).
The method used to arrive at ClogP is described elsewhere
(10). It should be noted that for the
tri-n-alkyltin compounds tested there is good agreement
between ClogP and experimentally determined values (see Table 5)
(17).
Calculation of dissociation constants.
The dissociation
constants (Kd) of the tri-n-alkyltin
chlorides were calculated from the variation of the conductances of the
compounds as a function of the concentrations (9). The conductances were measured with a YSI model 33 conductance meter. The
conductance cell and solutions were kept at a constant temperature (25°C). The inverse of the equivalent conductance (1/
) was plotted against the specific conductance (L). The intercept is the
inverse of the equivalent conductance (1/
o) at infinite
dilution. The Kd is found from the slopes of the
linear portions of the lines: slope = (1/
0)2 (1,000/Kd).
The conductance of each compound is the average of at least five
independent measurements.
Multivariate analysis.
Multivariate analysis of the
determinants of the ratios was performed by use of the ordinary
least-squares method. The regression package was the TSP package (TSP
International, Palo Alto, Calif.). Explanatory variables included the
number of alkyl carbons in the tri-n-alkyltin chlorides
(CARBON), ClogP, the molecular volumes (MV) and total surface areas
(TSA) of the molecules (13), and the measured
Kd of the compounds. The specific form of the
regression equation is as follows: ratio = C + B1 CARBON + B2
ClogP + B3 MV + B4 TSA + B5
Kd. The number of observations was four.
 |
RESULTS |
Effect of hydrocarbon length on PDR5-modified drug
resistance.
Zone-of-inhibition assays were carried out with
various concentrations of tri-n-alkyltin compounds
containing groups from methyl to pentyl. The goal was to find
concentrations of different inhibitors that would give similar zone
diameters for the wild-type strain. These concentrations were then used
to determine the zone diameters for the mutant strain. These results
are shown in Table 1. The data were
collected for a range of inhibitor concentrations (usually at least
10-fold). An easy comparison of the two strains can be made by dividing
the zone diameter found for the mutant by that found for the wild type.
A ratio of 1.0 indicates no difference in the zones between the
wild-type and mutant strains. In general, the reproducibilities of the
zones are fairly good. For the most part, as the molar concentration
increases, the diameter of the zone also increases in the expected
nonlinear fashion, although a few exceptions are observed. These data
can be used to generate curves for zones of lowest and highest
concentrations and are shown in Fig. 1.
In both cases, the peak ratio is highest with the propyl compound and
then declines. In fact, as Table 1 confirms, the same pattern is
observed for any diameter selected for comparison. Therefore, of the
five compounds analyzed, tri-n-propyltin chloride is the
strongest PDR5 substrate, while the pentyl and methyl
compounds are very weak.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Relationship between the ratio of zones of inhibition
and the number of carbons in the tri-n-alkyltin chlorides
and the concentrations of tri-n-alkyltin chlorides. The
ratio is defined as the zone of inhibition with JW436 divided by the
zone of inhibition with RW2802. The solid curve ( ) is for zones of
inhibition at the lowest concentration and the broken curve ( ) is
for zones of inhibition at the highest concentration of
tri-n-alkyltin chlorides.
|
|
Comparison of results from zone-of-inhibition assays and
fixed-concentration assays.
The quantitative comparisons made in
the zone-of-inhibition assays with tri-n-alkyltin chlorides
are valid provided that the diffusion of the compound from the disk is
not rate limiting. Because we could not eliminate this possibility
entirely, a second approach was devised. For each inhibitor, a series
of media in which the concentrations of the tri-n-alkyltin
compounds varied by twofold were made. The mutant (JG436) and the wild
type (RW2802) were spotted in duplicate on each petri dish containing a
specific drug concentration. The highest concentration of inhibitor
permitting growth of the strains is shown in Table
2 for tri-n-ethyltin, tri-n-propyltin, tri-n-butyltin, and
tri-n-pentyltin chlorides. Significantly, the results
derived from this experiment mirror those found with the
zone-of-inhibition assays. Thus, the greatest difference between the
strains is the ability to grow on tri-n-propyltin chloride.
In contrast, no distinction can be made with tri-n-pentyltin chloride, suggesting that the difference is less than twofold and that
the zone-of-inhibition assay is more sensitive for this inhibitor.
PDR5 substrate specificity as a function of anion
composition.
The ability of PDR5 to mediate resistance
is not strongly influenced by anion composition, as indicated by the
data shown in Table 3. The relatively
strong PDR5 substrate specificity of
tri-n-butyltin chloride is also observed with the bromide
and acetate compounds. In contrast, we also observed that
tri-n-phenyltin chloride, tri-n-phenyltin
acetate, and tri-n-phenyltin hydroxide are all relatively
weak substrates, with ratios of about 1.1 to 1.2 (Table 3).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Effect of a counterion on zones of inhibition with
tributyltin and triphenyltin compounds for RW2802 (PDR5)
and JG436 (pdr5)a
|
|
PDR5 substrate specificity as a function of
Kd.
The ability of the tri-n-alkyltin
chlorides and other inhibitors to dissociate was determined by
measuring their conductances in 95% ethanol as described in Materials
and Methods. The Kd values for the five
tri-n-alkyltin compounds are shown in Table
4. Unlike hydrophobicity, which increases
with an increase in the hydrocarbon chain length,
Kd and thus ionization capability decrease.
Taken by themselves, these data can be interpreted in one of two ways. The ionization capability of a PDR5 substrate might be
relatively unimportant. Alternately, ionization might be necessary but
insufficient.
PDR5 substrate specificity as a function of
hydrophobicity.
It has been proposed that hydrophobicity is a
central feature of MDR1 substrate recognition
(5). The data shown in Table 5
indicate that, as expected, logP increases markedly as the length of
the hydrocarbon chain increases in the tri-n-alkyltin chlorides. In contrast, as noted above, the ability of the
PDR5 gene product to mediate resistance rises and then falls
as a function of chain length. Thus, there is no obvious direct
relationship between hydrophobicity and the ability of a
tri-n-alkyltin compound to undergo efflux mediated by the
PDR5 gene product. This conclusion also can be drawn from
the data shown in Table 3. Although tri-n-butyltin chloride
and tri-n-butyltin acetate have P values that differ by
10-fold, they are equal within experimental error as PDR5
substrates. One could argue for a model of recognition based upon a
range of hydrophobicity values. This does not appear to be the case for
the PDR5 gene product, as indicated by the data shown in
Table 5, which also shows logP values and zones of inhibition for
additional substrates of fairly diverse structures. As an example,
tri-n-phenyltin chloride is a weak substrate, yet it has a
logP value between those of the very strong substrates
tri-n-propyl chloride and tri-n-butyl chloride.
Cycloheximide and lincomycin, which are medium to strong
PDR5 substrates, like tri-n-ethyl chloride and tri-n-butyl chloride, have logP values that are negative.
Chloramphenicol, a strong PDR5 substrate (15), is
only modestly hydrophobic, with a logP estimated at 0.69. The
multivariate analysis shows that for the coefficient on ClogP, the
Student t test value of
1.298 indicates that the
coefficient is not statistically significant. Accordingly, the null
hypothesis that ClogP has no influence on ratios cannot be rejected.
The results also show that the ratios are directly related to the
number of alkyl carbons and TSA and inversely related to the MV and
Kd.
View this table:
[in this window]
[in a new window]
|
TABLE 5.
logP values and ratios of zones of inhibition with
pertinent inhibitors for RW2802 (PDR5) and
JG436 (pdr5)
|
|
Effect of mutations in SNQ2 and SIN4.
It is now established that the SNQ2 and SIN4
proteins mediate resistance to some of the same inhibitors as the
PDR5 protein (4, 16). The SNQ2 protein
is an ATP-binding cassette transporter with high homology to the
PDR5 protein, while SIN4 encodes a global transcriptional regulator (7). Interpretation of our data
might be confounded if SNQ2 and SIN4 mediated
resistance to some but not all of the tin compounds. The data in Table
6 demonstrate that mutations in either of
these genes fail to alter inhibition by the tin compounds in
zone-of-inhibition assays.
 |
DISCUSSION |
The PDR5 protein causes the efflux of a very large
array of cellular inhibitors (8, 14). To understand the
chemical basis for PDR5 specificity, we compared the
relative sensitivities of isogenic mutant and wild-type strains toward
a group of simple, structurally related tri-n-alkyltin
chloride inhibitors of mitochondrial ATPase. Using a quantitative
zone-of-inhibition assay, we determined that tri-n-propyltin
chloride was the strongest PDR5 substrate of the five
compounds tested. In contrast, the methyl and pentyl compounds were
very weak. Based on earlier work (11), it is assumed that
the differences in the zones reflect differences in the ability of the
strains to cause efflux of the inhibitor in question, because this is
the only known difference between the otherwise isogenic strains.
The zone-of-inhibition assay is subject to the criticism that if
inhibitor diffusion is the limiting step, the diameter of the
corresponding zone might be artificially small and erroneous conclusions could be drawn in comparisons of different
tri-n-alkyltin chlorides. A second approach in which two
strains were spotted on a series of media containing fixed
concentrations of each inhibitor was therefore used. Using this assay,
we drew the same conclusions with respect to the relative
PDR5 substrate strengths of the tri-n-alkyltin chlorides. Thus, the greatest difference between the strains was observed with tri-n-propyltin chloride. Modest differences
were found with tri-n-butyl and tri-n-ethyltin
chlorides (Table 2). It should be pointed out, however, that the
zone-of-inhibition assay is more sensitive. Using this latter assay, we
observed a small but significant difference between the PDR5
and the pdr5 strains when tri-n-pentyltin
chloride was tested. No difference was found with the
fixed-concentration approach.
The two methods do, however, yield different orders of relative
toxicity. With the zone-of-inhibition assay, toxicity can be
approximately determined by finding what concentration gives the same
diameter in the wild-type strain. Based upon the concentration of
tri-n-alkyltin chlorides giving a zone of about 1.7 cm, the order of increasing toxicity is methyl, ethyl, butyl, pentyl, and
propyl. In the second approach, toxicity is determined from the lowest
concentration preventing the growth of the wild-type strain. With this
criterion, the order of increasing toxicity is methyl, ethyl, propyl,
pentyl, and butyl. It is likely that the toxicity estimate from the
fixed-concentration assay is more accurate.
Once the zone-of-inhibition data were collected, the hydrophobicity,
anion composition, and dissociation properties of the inhibitors were
analyzed. Our study with the tri-n-alkyltin chlorides and
different anions rules out hydrophobicity and anion composition as the
major parameters in the PDR5-mediated resistance of
substrates from tri-n-alkyltin chlorides and from other
inhibitors of diverse structures. For instance, cycloheximide, a strong
PDR5 substrate, is quite hydrophilic, whereas the
hydrophobic compounds triphenyltin chloride and
tri-n-pentyltin chloride are relatively weak. The range in
logP values (Table 3) for effective substrates is more than 5 orders of magnitude.
The zone-of-inhibition curve (Fig. 1) can be interpreted in two ways.
The parabolic shape may indicate two interacting parameters with
opposing effects on PDR5 substrate affinity. Alternatively, the plot may represent recognition based on a range values for some
chemical property, for example, the size of the alkyl groups, as
represented by the MV and the TSA. The multivariate analysis shows that the ratios are related directly to TSA and inversely to MV. Because most of the known PDR5 substrates have
ionizable groups, it is not unreasonable to suggest that there is a
relationship between substrate affinity and the proportion of the
substrate in the ionic form. This suggestion is also confirmed by a
significant relationship between ratio and Kd,
as determined by the multivariate analysis.
It is important to compare the behavior of PDR5 with that of
the well-studied mammalian MDR1 locus. There are two major
studies on the chemical specificity of the latter (15, 18).
Both were concerned primarily with compounds that bind to and modulate
the multidrug transporter so that it is less active (as opposed to compounds whose efflux from cells is mediated by the MDR1
product). Both studies concluded that hydrophobicity was the principal
chemical property shared by the modulators. Zamora et al.
(18) also analyzed the chemical properties of anticancer
agents known to be transported out of cells by the MDR1
P-glycoprotein and noted that most were hydrophobic and cationic. There
were, however, several exceptions (for instance, doxorubicin, which is
a strong MDR1 substrate but has a negative logP value). Our
data suggest that PDR5-mediated efflux does not have the
strict requirements of the flippase model proposed for the
MDR1 P-glycoprotein (5). Thus, at least some of
the PDR5 protein substrates are hydrophilic and probably do not have to be intercalated into the plasma membrane prior to interaction with the efflux apparatus. It is therefore not clear whether the PDR5 and MDR1 proteins are really
different in their means of recognizing or causing efflux of their substrates.
 |
ACKNOWLEDGMENTS |
We appreciate the assistance of Kevin Forbes in interpreting and
performing the multivarent analysis. We thank James Keeven for
suggesting the experiment described in Table 2 and David Stillwell and
Scott Moye-Rowley for strain and plasmid donations.
This work was supported by a grant from the National Science Foundation
(MCB-9603553).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biology, The Catholic University of America, Washington, DC 20064. Phone: (202) 319-5722. Fax: (202) 319-5721. E-mail:
Golin{at}cua.edu.
 |
REFERENCES |
| 1.
|
Balzi, E.,
M. Wang,
S. Leterme,
L. Van Dyck, and A. Goffeau.
1994.
PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcriptional regulator PDR1.
J. Biol. Chem.
269:2206-2214[Abstract/Free Full Text].
|
| 2.
|
Cain, K., and D. E. Griffiths.
1977.
Studies of energy-linked reaction: localization of the site of action of trialkyltin in yeast mitochondria.
Biochem. J.
162:575-580[Medline].
|
| 3.
|
Egner, R.,
F. Rosenthal,
A. Kralli,
D. Sanglard, and K. Kuchler.
1998.
Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter.
Mol. Biol. Cell
9:523-543[Abstract/Free Full Text].
|
| 4.
|
Fleckenstein, A.,
J. Shallom, and J. Golin.
1999.
A PDR5-independent pathway of multi-drug resistance regulated by the SIN4 gene product.
Yeast
15:133-137[CrossRef][Medline].
|
| 5.
|
Gottesmann, M., and I. Pastan.
1993.
Biochemistry of multidrug resistance mediated by the multidrug transporter.
Annu. Rev. Biochem.
62:385-427[CrossRef][Medline].
|
| 6.
|
Gros, P.,
R. Dhir,
J. Croop, and F. Talbot.
1991.
A single amino acid substitution strongly modulates the activity and substrate specificity of mouse mdr1 and mdr3 drug efflux pumps.
Proc. Natl. Acad. Sci. USA
88:7289-7293[Abstract/Free Full Text].
|
| 7.
|
Jiang, Y. W., and D. J. Stillman.
1995.
Regulation of HIS4 expression by the Saccharomyces cerevisiae SIN4 transcriptional regulator.
Genetics
140:103-114[Abstract].
|
| 8.
|
Kolaczkowski, M.,
M. Vanderest,
A. Eybularz-Kolaczkowski,
J. Soumillion,
W. Konings, and A. Goffeau.
1996.
Anticancer drugs, ionophoric peptides and steroids as substrates of the yeast multidrug transporter Pdr5p.
J. Biol. Chem.
271:31543-31548[Abstract/Free Full Text].
|
| 9.
|
Kraus, C. A., and C. C. Callis.
1923.
Studies relating to the metallo-organic compounds. I. Introduction. II. The equivalent conductance of trimethylstannyl chloride in ethyl alcohol.
J. Am. Chem. Soc.
45:2624-2632[CrossRef].
|
| 10.
|
Leo, A. J.
1993.
Calculating log POCT from structures.
Chem. Rev.
93:1281-1306[CrossRef].
|
| 11.
|
Leonard, P. J.,
P. K. Rathod, and J. Golin.
1994.
Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux.
Antimicrob. Agents Chemother.
38:2492-2494[Abstract/Free Full Text].
|
| 12.
|
Loo, A. J., and D. M. Clark.
1993.
Functional consequences of proline mutations in the predicted transmembrane domains of P-glycoprotein.
J. Biol. Chem.
268:3143-3149[Abstract/Free Full Text].
|
| 13.
|
Luedke, E.,
E. Lucero, and G. Eng.
1991.
Molecular volume as a predictor of organotin biotoxicity.
Main Group Met. Chem.
14:59-66.
|
| 14.
|
Meyers, S.,
W. Schauer,
E. Balzi,
M. Wagner,
A. Goffeau, and J. Golin.
1992.
Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5.
Curr. Genet.
21:431-436[CrossRef][Medline].
|
| 15.
|
Nogac, I.,
K. Kohno,
J. Kikuchi,
J. Kawano, and M. Akuyama.
1989.
Analysis of structural features of dihydropyridine analogs needed to reverse MDR and inhibit photo affinity labeling of P-glycoprotein.
Biol. Pharm.
38:519-517.
|
| 16.
|
Servos, J.,
E. Hasse, and M. Brendel.
1993.
Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases.
Mol. Gen. Genet.
236:214-218[CrossRef][Medline].
|
| 17.
|
Wulf, R. G., and K. H. Byington.
1975.
On the structure-activity relationships and mechanism of organotin induced nonenergy dependent swelling of liver mitochondria.
Arch. Biochem. Biophys.
167:176-185[CrossRef][Medline].
|
| 18.
|
Zamora, J.,
H. L. Pearce, and W. T. Beck.
1988.
Physical-chemical properties shared by compounds that modulate MDR in human leukemic cells.
Mol. Pharmacol.
33:454-462[Abstract].
|
Antimicrobial Agents and Chemotherapy, January 2000, p. 134-138, Vol. 44, No. 1
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sugiyama, A., Shitan, N., Sato, S., Nakamura, Y., Tabata, S., Yazaki, K.
(2006). Genome-wide analysis of ATP-binding cassette (ABC) proteins in a model legume plant, Lotus japonicus: comparison with Arabidopsis ABC protein family. DNA Res
13: 205-228
[Abstract]
[Full Text]
-
Tutulan-Cunita, A. C., Mikoshi, M., Mizunuma, M., Hirata, D., Miyakawa, T.
(2005). Mutational analysis of the yeast multidrug resistance ABC transporter Pdr5p with altered drug specificity. GENES CELLS
10: 409-420
[Abstract]
[Full Text]
-
Golin, J., Ambudkar, S. V., Gottesman, M. M., Habib, A. D., Sczepanski, J., Ziccardi, W., May, L.
(2003). Studies with Novel Pdr5p Substrates Demonstrate a Strong Size Dependence for Xenobiotic Efflux. J. Biol. Chem.
278: 5963-5969
[Abstract]
[Full Text]
-
Wada, S.-i., Niimi, M., Niimi, K., Holmes, A. R., Monk, B. C., Cannon, R. D., Uehara, Y.
(2002). Candida glabrata ATP-binding Cassette Transporters Cdr1p and Pdh1p Expressed in a Saccharomyces cerevisiae Strain Deficient in Membrane Transporters Show Phosphorylation-dependent Pumping Properties. J. Biol. Chem.
277: 46809-46821
[Abstract]
[Full Text]